Avenue Therapeutics, Inc. (ATXI)
OTCMKTS · Delayed Price · Currency is USD
0.7318
0.00 (0.00%)
Sep 16, 2025, 9:30 AM EDT
Avenue Therapeutics Market Cap
Avenue Therapeutics has a market cap or net worth of $2.66 million as of September 16, 2025. Its market cap has decreased by -36.36% in one year.
Market Cap
2.66M
Enterprise Value
-1.89M
Revenue
1.40M
Ranking
n/a
PE Ratio
0.75
Stock Price
$0.73
Market Cap Chart
Since June 27, 2017, Avenue Therapeutics's market cap has decreased from 27.57M to 2.66M, a decrease of -90.35%. That is a compound annual growth rate of -24.75%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Sep 15, 2025 | 2.66M | -35.25% |
| Dec 31, 2024 | 4.11M | 92.60% |
| Dec 29, 2023 | 2.13M | -61.53% |
| Dec 30, 2022 | 5.54M | -70.79% |
| Dec 31, 2021 | 18.98M | -80.95% |
| Dec 31, 2020 | 99.64M | -37.70% |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2018 | Upgrade Pro | Upgrade Pro |
| Dec 29, 2017 | Upgrade Pro | Upgrade Pro |
| Jun 27, 2017 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Nika Pharmaceuticals | 982.68M |
| Veradigm | 789.71M |
| Elite Pharmaceuticals | 750.21M |
| Tian'an Technology Group | 723.74M |
| Glass House Brands | 566.73M |
| Northwest Biotherapeutics | 390.10M |
| CytoDyn | 358.38M |
| American Oncology Network | 353.52M |